Variability of ferritin measurements in chronic kidney disease; implications for iron management

被引:47
|
作者
Ford, Bradley A. [1 ]
Coyne, Daniel W. [2 ]
Eby, Charles S. [1 ,2 ]
Scott, Mitchell G. [1 ]
机构
[1] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Washington Univ, Dept Med, St Louis, MO 63110 USA
关键词
ferritin; iron; hemodialysis; anemia; ANEMIC HEMODIALYSIS-PATIENTS; HIGH SERUM FERRITIN; INTRAVENOUS IRON; TRANSFERRIN SATURATION; DIALYSIS PATIENTS; IV IRON; DEFICIENCY; GLUCONATE; TRIAL; REDUCTION;
D O I
10.1038/ki.2008.526
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Serum ferritin levels are a proxy measure of iron stores; existing guidelines for managing anemia in hemodialysis patients suggest that serum ferritin concentrations should be maintained at > 200 ng/ml. The KDOQI recommendations further state there is insufficient evidence advocating routine intravenous iron when ferritin levels exceed 500 ng/ml. Here we determined the interassay differences and short-term intraindividual variability of serum ferritin measurements in patients on chronic hemodialysis to illustrate how these variances may affect treatment decisions. Intermethod variations of up to 150 ng/ml were found comparing six commonly used ferritin assays that evaluated thirteen pools of serum from hemodialysis and nonhemodialysis patients. The intraindividual variability for ferritin in 60 stable hemodialysis patients ranged between 2-62% measured over an initial two-week period and from 3-52% when factored over a six-week period. Our results suggests that single serum ferritin values should not be used to guide clinical decisions regarding treatment of chronic hemodialysis patients with intravenous iron due to significant analytical and intraindividual variability.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 50 条
  • [31] Insights into the gut-kidney axis and implications for chronic kidney disease management in cats and dogs
    Summers, Stacie
    Quimby, Jessica
    VETERINARY JOURNAL, 2024, 306
  • [32] Serum Ferritin < 70 mu g/L Predicts Functional Iron Deficiency in Patients with Chronic Kidney Disease
    Garg, Neha
    Kotru, Mrinalini
    Yadav, Anil
    Rusia, Usha
    Sikka, Meera
    Kalra, Om Parkash
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2018, 29 (05) : 1035 - 1041
  • [33] The use of soluble transferrin receptor-ferritin index for monitoring iron supplementation in chronic kidney disease patients
    Ooi, C.
    Lepage, N.
    Nieuwenhuys, E.
    Filler, G.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1523 - 1523
  • [34] Iron management and exercise training in individuals with chronic kidney disease: lived experiences
    Lightfoot, Courtney J.
    Greenwood, Sharlene A.
    Asgari, Elham
    Banerjee, Debasish
    Bhandari, Sunil
    Burton, James O.
    Kalra, Philip A.
    Mccafferty, Kieran
    Oliveira, Benjamin A.
    Reid, Chante
    Swift, Pauline A.
    Wheeler, David C.
    Wilkinson, Thomas J.
    Bramham, Kate
    Smith, Alice C.
    CLINICAL KIDNEY JOURNAL, 2025, 18 (01)
  • [35] Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease
    Roger, Simon D.
    CLINICAL KIDNEY JOURNAL, 2017, 10 : 9 - 15
  • [36] Safety Issues With Intravenous Iron Products in the Management of Anemia in Chronic Kidney Disease
    Hayat, Amir
    CLINICAL MEDICINE & RESEARCH, 2008, 6 (3-4) : 93 - 102
  • [37] Hypoglycemia and Glycemic Variability in Chronic Kidney Disease
    Ahmad, Iram
    Batacchi, Zona
    Robinson-Cohen, Cassianne
    Zelnick, Leila
    Curtin, Laura
    Dighe, Ashveena
    Lum, Dawn
    Trence, Dace
    Hirsch, Irl B.
    De Boer, Ian H.
    DIABETES, 2017, 66 : LB1 - LB1
  • [38] Hemoglobin Variability in Anemia of Chronic Kidney Disease
    Kalantar-Zadeh, Kamyar
    Aronoff, George R.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (03): : 479 - 487
  • [39] Immunosenescence, gut dysbiosis, and chronic kidney disease: Interplay and implications for clinical management
    Lee, Tao Han
    Chen, Jia-Jin
    Wu, Chao-Yi
    Lin, Ting-Yun
    Hung, Szu-Chun
    Yang, Huang-Yu
    BIOMEDICAL JOURNAL, 2024, 47 (02)
  • [40] Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
    Macdougall, Iain C.
    Bircher, Andreas J.
    Eckardt, Kai-Uwe
    Obrador, Gregorio T.
    Pollock, Carol A.
    Stenvinkel, Peter
    Swinkels, Dorine W.
    Wanner, Christoph
    Weiss, Guenter
    Chertow, Glenn M.
    KIDNEY INTERNATIONAL, 2016, 89 (01) : 28 - 39